Madam Speaker, I cannot see why.
Millions of Canadians suffer from age-related macular degeneration, or AMD. This presently incurable disease starts with a loss of visual acuity in the centre of the eye. Eventually, the condition almost always results in blindness.
Many of our constituents and even members of our own families are affected, but now there are emerging treatment options. For instance, a new non-invasive device from a Canadian company has been clinically tested in Canada, and it offered positive results to all who were actively treated. It is less expensive than the present course of treatment, which only slows AMD's progression. There are other innovations on the horizon as well.
Unfortunately, Health Canada has been studying and delaying the approval of this life-changing treatment for almost two years. I am not questioning the thoroughness or importance of Health Canada's work. However, I am saying that procrastination and delays are not acceptable when our loved ones are going blind.
I cannot see why.